MassDevice.com +5 | The top 5 medtech stories for November 3, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Incoming Getinge CEO Perjos has industrial background Swedish medical technology firm Getinge said today that it found a new CEO, sending up its battered shares, but some analysts said the incoming industrialist lacked the necessary sector experience. Getinge has been through a turbulent period, firing CEO Alex Myers in August after only 18 months in the job and replacing its CFO in September. Read more 4. Report: Valeant explores sales of eye surgery biz Valeant Pharmaceuticals is reportedly exploring a sale of its eye surgery business that could be worth as much as $2.5 billion. The sale process is still in early stages and may not even happen, but the Laval, Canada-based company is trying to shed some of the debt it took on through its many acquisitions, according to the Wall Street Journal. Valeant is in discussions with 3rd parties for “various divestitures”, according to the newspaper, although Valeant won’t give up the contact lenses, solutions and eye drugs that it acquired with its $9 billion purchase of Bausch & Lomb in 2013. Read more 3. Wright...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Blog Plus 5 Source Type: news